Eyepoint Pharmaceuticals Inc Capital Reinvestment Ratio
Eyepoint Pharmaceuticals Inc capital reinvestment ratio. Eyepoint Pharmaceuticals Inc (EYPT) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($57.02 Million) in capital expenditures ($396.00K). Check Eyepoint Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Eyepoint Pharmaceuticals Inc (2010–2023)
Capital reinvestment ratio of Eyepoint Pharmaceuticals Inc from 2010 to 2023. This chart tracks Eyepoint Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Eyepoint Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
Eyepoint Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2010–2023)
Eyepoint Pharmaceuticals Inc capital reinvestment ratio by year from 2010 to 2023. For the full cash flow conversion analysis, see Eyepoint Pharmaceuticals Inc (EYPT) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.86x | $1.88 Million | $3.48 Million | ▲ +11780.6% |
| 2015 | 0.02x | $10.30 Million | $161.00K | ▲ +931.8% |
| 2010 | 0.00x | $9.90 Million | $15.00K | — |